外阴癌新辅助化疗

邓 浩, 王建六

中国实用妇科与产科杂志 ›› 2023, Vol. 39 ›› Issue (7) : 698-701.

中国实用妇科与产科杂志 ›› 2023, Vol. 39 ›› Issue (7) : 698-701. DOI: 10.19538/j.fk2023070106
专题笔谈

外阴癌新辅助化疗

作者信息 +

Neoadjuvant chemotherapy in vulvar cancer. 

Author information +
文章历史 +

摘要

外阴癌的发病率低,处理相对复杂,尤其是局部晚期外阴癌患者。近些年以来,有关外阴癌新辅助化疗的研究逐渐增多,通过新辅助化疗可缩小肿瘤病灶,避免手术切除尿道、肛门等器官,保留脏器功能,提高患者生活质量。但目前研究仍然较少,且多数为回顾性研究,仍需要进一步深入研究评估其治疗效果及新辅助化疗方案。

Abstract

The incidence rate of vulvar cancer is low and the management is complex,especially in patients with locally advanced vulvar cancer. In recent years,researches on neoadjuvant chemotherapy for vulvar cancer have gradually increased. Through neoadjuvant chemotherapy,tumor lesions can be reduced to avoid surgical removal of organs such as the urethra and anus,preserving organ function,and improving patient quality of life. However,there are still relatively few studies at present,and most of them are retrospective studies. Further research is still needed to evaluate the therapeutic effect and neoadjuvant chemotherapy regimen.

关键词

外阴癌 / 新辅助化疗 / 预后

Key words

vulvar cancer / neoadjuvant chemotherapy / prognosis

引用本文

导出引用
邓 浩, 王建六. 外阴癌新辅助化疗[J]. 中国实用妇科与产科杂志. 2023, 39(7): 698-701 https://doi.org/10.19538/j.fk2023070106
DENG Hao, WANG Jian-liu. Neoadjuvant chemotherapy in vulvar cancer. [J]. Chinese Journal of Practical Gynecology and Obstetrics. 2023, 39(7): 698-701 https://doi.org/10.19538/j.fk2023070106
中图分类号: R737.35   

基金

国家重点研发计划(2022YFC2704400)

Accesses

Citation

Detail

段落导航
相关文章

/